Business Description
Sisram Medical Ltd
ISIN : IL0011418113
Compare
Compare
Traded in other countries / regions
01696.Hong KongSRAMF.USA IPO Date
2017-09-19Description
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.58 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 1.34 | |||||
| Interest Coverage | 15.92 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.32 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.2 | |||||
| 3-Year EBITDA Growth Rate | 21.7 | |||||
| 3-Year EPS without NRI Growth Rate | 31.9 | |||||
| 3-Year FCF Growth Rate | 26.9 | |||||
| 3-Year Book Growth Rate | 9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.65 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.55 | |||||
| 9-Day RSI | 53.38 | |||||
| 14-Day RSI | 50.14 | |||||
| 6-1 Month Momentum % | -8.51 | |||||
| 12-1 Month Momentum % | -38.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.62 | |||||
| Quick Ratio | 1.78 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 223.28 | |||||
| Days Sales Outstanding | 87.79 | |||||
| Days Payable | 39.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.57 | |||||
| Dividend Payout Ratio | 0.44 | |||||
| 3-Year Dividend Growth Rate | 16.1 | |||||
| Forward Dividend Yield % | 4.57 | |||||
| 5-Year Yield-on-Cost % | 4.76 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 3.29 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.6 | |||||
| Operating Margin % | 10.53 | |||||
| Net Margin % | 6.61 | |||||
| FCF Margin % | 9.29 | |||||
| ROE % | 5.25 | |||||
| ROA % | 3.83 | |||||
| ROIC % | 6.71 | |||||
| ROC (Joel Greenblatt) % | 22.04 | |||||
| ROCE % | 6.43 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.68 | |||||
| Forward PE Ratio | 5.15 | |||||
| PE Ratio without NRI | 8.68 | |||||
| Shiller PE Ratio | 8.34 | |||||
| Price-to-Owner-Earnings | 8.71 | |||||
| PEG Ratio | 0.61 | |||||
| PS Ratio | 0.58 | |||||
| PB Ratio | 0.45 | |||||
| Price-to-Tangible-Book | 1.06 | |||||
| Price-to-Free-Cash-Flow | 6.17 | |||||
| Price-to-Operating-Cash-Flow | 5.14 | |||||
| EV-to-EBIT | 5.42 | |||||
| EV-to-EBITDA | 5.42 | |||||
| EV-to-Revenue | 0.51 | |||||
| EV-to-FCF | 5.26 | |||||
| Price-to-Projected-FCF | 0.38 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.46 | |||||
| Price-to-Graham-Number | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 2.15 | |||||
| Earnings Yield (Greenblatt) % | 18.45 | |||||
| FCF Yield % | 16.15 | |||||
| Forward Rate of Return (Yacktman) % | 20.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sisram Medical Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 2,783.454 | ||
| EPS (TTM) (HK$) | 0.394 | ||
| Beta | 1.62 | ||
| Volatility % | 43.99 | ||
| 14-Day RSI | 50.14 | ||
| 14-Day ATR (HK$) | 0.1668 | ||
| 20-Day SMA (HK$) | 3.4595 | ||
| 12-1 Month Momentum % | -38.58 | ||
| 52-Week Range (HK$) | 2.75 - 5.5 | ||
| Shares Outstanding (Mil) | 468.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sisram Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sisram Medical Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sisram Medical Ltd Frequently Asked Questions
What is Sisram Medical Ltd(HKSE:01696)'s stock price today?
The current price of HKSE:01696 is HK$3.42. The 52 week high of HKSE:01696 is HK$5.50 and 52 week low is HK$2.75.
When is next earnings date of Sisram Medical Ltd(HKSE:01696)?
The next earnings date of Sisram Medical Ltd(HKSE:01696) is .
Does Sisram Medical Ltd(HKSE:01696) pay dividends? If so, how much?
The Dividend Yield %  of Sisram Medical Ltd(HKSE:01696) is 4.57% (As of Today), Highest Dividend Payout Ratio of Sisram Medical Ltd(HKSE:01696) was 0.48. The lowest was 0.13. And the median was 0.28. The  Forward Dividend Yield % of Sisram Medical Ltd(HKSE:01696) is 4.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers